---
title: CROs offering Phase III Clinical Trials with Peptide
path: /explore/phase-3-clinical-trials/peptide
companies_count: 9
---

# CROs offering Phase III Clinical Trials with Peptide

9 published CROs match Phase III Clinical Trials and Peptide.

Locations in this set include United States, China, France, India, United Kingdom, and 30 countries.

Capabilities that show up most often in this set: Phase I Clinical Trials, Phase II Clinical Trials, Biostatistics & Statistical Programming, Clinical Trial Services, and Data Management & eClinical.

## Matching companies

- [Aliri Bioanalysis](/companies/aliribio)
  - Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.
- [Certara](/companies/certara)
  - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Premier Research](/companies/premier-research)
  - Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
- [Protheragen](/companies/obesityscientific)
  - Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Tigermed](/companies/tigermedgrp)
  - Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
- [WuXi AppTec](/companies/wuxiapptec)
  - Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
- [ethica CRO](/companies/ethicacro)
  - ethica CRO is the first contract research organization in the world to achieve HRPP accreditation from three distinct accrediting bodies, specializing in medical aesthetics, dermatology, and clinical trial management with a focus on ethical excellence and participant safety.